ニュース

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down
FRANKFURT, Germany (AP) — Pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday ...
ABC News2 日
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down FRANKFURT, Germany -- Pharmaceutical company Novo Nordisk A/S, maker of blockbuster ...
Reuters7 日
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
May 12 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Sunday its drug Zepbound was superior to Novo Nordisk's (NOVOb.CO), opens new tab Wegovy across five weight-loss targets such as ...
Boston Herald2 日
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...
U.S. News & World Report2 日
CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy, to Step Down in Wake of Share Price Drop
CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy, to Step Down in Wake of Share Price Drop FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster ...
Healthline3 日
FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know
Share on Pinterest A Wegovy weight loss pill from Novo Nordisk is forthcoming, providing an alternative to injectable GLP-1 drugs. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty Images Federal ...
CBS News2 日
Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement" with the company's board of directors, citing "recent ...